AI Drug Discovery

Business

Cuban's Healthcare Poll Exposes 'Pick-Your-Pain' Dilemma: Deductibles Edge Out Premiums in Voter Frustration

A social media poll by billionaire Mark Cuban reveals a near-even split on which part of U.S. health insurance is more financially painful—premiums or deductibles. The results, and the outpouring of personal stories in the replies, underscore a system many describe as forcing impossible choices amid relentlessly rising costs.

Jan 30, 2026

Business

FDA Greenlights Spectrum Dynamics' AI-Powered Imaging Platform, Boosting Nuclear Medicine Precision

The FDA clearance of Spectrum Dynamics' Veritas.AI platform marks a significant step forward for nuclear imaging, promising to cut scan times in half and enhance image clarity for critical applications like cancer theranostics.

Jan 30, 2026

Business

Immunocore Gains Analyst Backing as Late-Stage Trials Loom

Immunocore Holdings (NASDAQ: IMCR) has drawn renewed bullish sentiment from analysts at H.C. Wainwright and UBS, who highlight the stock's potential as key Phase 3 trial data for its cancer immunotherapies approaches later this decade.

Jan 30, 2026

Business

Bidding War Sparks Rally for Warner Bros. Discovery, Value Fund Sees Opportunity

Amid a broader market rally, Warner Bros. Discovery's stock surged over 164% in the past year, driven by reported takeover interest. The Hotchkis & Wiley Large Cap Disciplined Value Fund highlighted the media giant as a key contributor in its latest investor letter, pointing to its attractive valuation in a frothy market.

Jan 30, 2026

Business

Boehringer Ingelheim Taps IQVIA to Power Global Data Overhaul, Aiming for AI-Driven Insights

The long-term strategic partnership will leverage IQVIA's data-as-a-service platform to unify and streamline commercial data across 59 countries, aiming to accelerate product launches and enhance decision-making for the pharmaceutical giant.

Jan 30, 2026

World

Remains and Jacket Discovered in Tasmanian Wilderness, Likely Ending Two-Year Search for Missing Belgian Hiker

Tasmanian police believe they have found the remains of Celine Cremer, a Belgian hiker missing since 2023, along with clothing items including a polar fleece jacket, following a renewed search near Philosopher's Falls.

Jan 30, 2026

World

England's Hidden Waste Scandal: Investigation Uncovers 517 Illegal Dumps, Exposing Systemic Failures

A nationwide investigation has revealed 517 illegal waste sites across England, some containing over 20,000 tonnes of material, raising urgent questions about the integrity of packaging waste management and corporate accountability.

Jan 30, 2026

Business

Argenta Silver Shares Slide 12% Despite Promising El Quevar Drill Results and $23M Raise

Argenta Silver Corp. sees its stock decline following the announcement of a new mineral discovery at its El Quevar project in Argentina and the completion of a substantial equity financing, highlighting the complex calculus investors face with junior mining explorers.

Jan 30, 2026

Business

Korro Bio Unveils RNA-Editing Therapy KRRO-121, Aiming to Redefine Ammonia Control for Rare Metabolic and Liver Disorders

At its Analyst Day, Korro Bio detailed its lead candidate KRRO-121, an RNA-editing therapeutic designed to tackle hyperammonemia in urea cycle disorders and hepatic encephalopathy by stabilizing a key liver enzyme, positioning it as a potential paradigm shift from current burdensome treatments.

Jan 30, 2026

Business

ResMed Posts Strong Q2 Growth, Eyes GLP-1 Tailwind and AI-Driven Innovation

ResMed reports robust revenue and margin expansion in its fiscal Q2 2026, driven by strong device and mask sales. Management highlights strategic investments in AI-powered patient tools and views GLP-1 medications as a potential catalyst for future demand.

Jan 30, 2026

Business

CFTC Chair Charts New Course for Prediction Markets, Vowing Clarity for Polymarket and Kalshi

In a major policy shift, the CFTC under new Chairman Michael Selig is drafting a comprehensive rulebook for event contracts, aiming to bring regulatory certainty to the fast-growing prediction market industry while fostering 'permissionless innovation.'

Jan 30, 2026

Business

CS Disco (LAW) Gains Analyst Backing Amid AI-Driven Growth, But Is It a Buy?

Jefferies raises price target on CS Disco following strong Q3 results fueled by its Cecilia AI platform, yet maintains a cautious 'Hold' rating as the company balances growth investments against profitability.

Jan 30, 2026

Business

Nuvation Bio's Ibtrozi Gains Favor on Strong Launch, Truist Raises Target

Truist Securities has increased its price target for Nuvation Bio, highlighting the promising early commercial traction of its oncology drug Ibtrozi, which is outpacing competitors in the ROS1 inhibitor space.

Jan 30, 2026

Business

Mineralys Therapeutics Submits New Drug Application for Hypertension Treatment Lorundrostat, Backed by Strong Clinical Data

Clinical-stage biopharma Mineralys Therapeutics has filed its New Drug Application for lorundrostat, a potential treatment for resistant hypertension, following positive results from multiple trials. The move positions the company for a potential 2026 market entry and has drawn upgraded price targets from analysts.

Jan 30, 2026

Business

Bank of America Bullish on Apellis, Upgrades to 'Buy' on Strong Drug Launch and Kidney Disease Prospects

Bank of America has upgraded Apellis Pharmaceuticals (APLS) to 'Buy,' citing robust early adoption of its drug Empaveli and significant undervaluation of its potential in treating rare kidney diseases, despite a more cautious outlook from Wells Fargo.

Jan 30, 2026

Business

UK Watchdog Probes Boots and Superdrug Over 'Misleading' Loyalty Pricing Tactics

A major consumer group has filed a complaint with the Competition and Markets Authority, alleging the pharmacy chains used inflated reference prices to make member discounts appear more substantial than they truly were.

Jan 30, 2026

Business

Hawaiian Electric's Phoenix Moment: A Major Bet Signals Confidence Post-Wildfire Settlement

A sophisticated zero-cost options trade by a large investor highlights a turning point for Hawaiian Electric Industries, as stabilized finances and capped liabilities pave the way for recovery.

Feb 3, 2026

Business

Lumentum's AI Pivot Fuels Growth, But Valuation Questions Loom

Lumentum Holdings Inc. has transformed from a consumer electronics supplier into a key player in AI infrastructure, driving a V-shaped recovery. While surging demand for high-speed optical modules paints a bullish picture, its premium valuation demands scrutiny.

Feb 3, 2026

Business

SpaceX to Acquire xAI in Share Swap Deal, Valuing Musk's AI Venture at Billions

Elon Musk's SpaceX is set to acquire his artificial intelligence startup xAI in a landmark share exchange, with investors offered 0.1433 SpaceX shares for each xAI share, according to a source familiar with the transaction. The deal underscores Musk's strategy of consolidating his tech empire amid fierce AI competition.

Feb 3, 2026

Business

Archer Aviation's 'Midnight' eVTOL Gains Altitude: Can Certification Unlock Urban Air Mobility?

As Archer Aviation advances toward FAA certification for its Midnight air taxi, bullish investors point to its strong liquidity and strategic partnerships. But with the company still pre-revenue and burning cash, the path to commercial launch by 2026 remains a high-stakes race against time and regulation.

Feb 3, 2026